In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance-Reference-Cited by-同舟云学术

In Vitro Analysis of Human Drug Glucuronidation and Prediction of in Vivo Metabolic Clearance

Published:2002-04-01 Issue:1 Volume:301 Page:382-390
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Soars M. G.,Burchell B.,Riley R. J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference46 articles.

1. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.;Bertz;Clin Pharmacokinet,1997

2. Metabolism of naphthalene to naphthalene dihydrodiol glucuronide in isolated hepatocytes and in liver microsomes

3. Burchell B Ethell B Coffey M Findlay K Jedlitschky G Soars M Smith D Hume R (2001) Inter-individual variation of UDP-glucuronosyltransferases and drug glucuronidation in man. in Interindividual Variability in Drug Metabolism in Man, eds Pacifici Pelkonen (Taylor and Francis Ltd. London, UK), pp 358–394.

4. Microsomal prediction ofin vivoclearance of CYP2C9 substrates in humans

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uridine 5′-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro–In Vivo Extrapolation (IVIVE);European Journal of Drug Metabolism and Pharmacokinetics;2024-04-20

2. Evaluation of commonin vitroassays for the prediction of oral bioavailability and hepatic metabolic clearance in humans;2024-02-28

3. ANDROMEDA by Prosilico and log D outperform human hepatocytes for the prediction of intrinsic hepatic metabolic clearance of carboxylic acids;2023-12-05

4. Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data;Frontiers in Pharmacology;2023-03-23

5. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans;Drug Metabolism and Disposition;2023-03-16